ImmuSmol's News
L-Kynurenine monoclonal antibody to stratify cancer patients - PLOS ONE article
04/20/2015
A recent PLOS ONE article shows that ImmuSmol's anti-L-Kynurenine-antibody can serve to stratify cancer patients for kynurenine pathway activity. Access the article...
The immune-brain axis: from molecules to behavior
03/02/2015
ImmuSmol is sponsoring the Symposium "The immune-brain axis: from molecules to behavior", held at the Hasselt University, Campus Diepenbeek, Belgium, on March 12th and 13th, 2015.
ImmuSmol's Small Molecule Antibodies in the Press
01/12/2015
Discover ImmuSmol's story, featured in the 2015 winter edition of the European Biotechnology Magazine.
Happy 2015 from ImmuSmol!
01/01/2015
Just a few words to thank our clients and partners and wish them a bright and joyful 2015.
ImmuSmol raises 500 000 € to advance cancer immunotherapy programme
09/23/2014
ImmuSmol is pleased to announce it has raised 500 000 € to progress its monoclonal antibodies for cancer immunotherapy to in vivo proof-of-concept (POC).